Opportunity ID: 316063

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-19-GWIRP-IA
Funding Opportunity Title: DoD Gulf War Illness, Idea Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 3
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: May 16, 2019
Last Updated Date: May 16, 2019
Original Closing Date for Applications: Oct 03, 2019
Current Closing Date for Applications: Oct 03, 2019
Archive Date: Nov 02, 2019
Estimated Total Program Funding: $800,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description:

Impact: Applications must articulate how results will lead to a clinical impact for Veterans with GWI even if a clinical impact is not an immediate outcome. All applications must focus on features of GWI and Veterans of the 1990-1991 Gulf War affected by GWI. It is the responsibility of the PI to clearly and explicitly articulate the project’s potential impact on GWI.



FY19 GWIRP Idea Award Topics of Special Interest: The FY19 GWIRP Idea Award has a special interest in the exploration of the topics listed below. Elucidation of mechanisms outside the context of GWI is not within the scope of this funding opportunity. Applicants are not restricted to this list and may propose studies in any other GWI research area relevant to the mission of the GWIRP and in the context of the Overarching Challenges.


Epidemiology of comorbidities and mortality, including gender or ethnic differences, or sinus, respiratory, gastrointestinal, sleep, or dermatological abnormalities as a component of GWI


Interactions among individual symptoms of GWI, including non-refreshing sleep, and how these symptom clusters affect health outcomes and Veterans’ health overall


Genetic factors predisposing individuals to GWI


Molecular signatures (e.g., biomarkers) underlying symptom clusters via genomic, proteomic, metabolic, or epigenetic technologies


Dysregulation of, or abnormal crosstalk between, human body organ systems (e.g., neuroinflammation, autonomic dysfunction). Particular emphasis is placed on the systems listed below. Note: Examination of parameters at both baseline and after challenge (stress, exercise, immune, etc.) and attention to long-term and latent effects of toxicant exposures to closely represent the current status of GWI patients should be considered. Neurological system (central, peripheral, autonomic, and/or neuromuscular)


Immune system


Endocrine, exocrine, and/or excretory systems, with special attention to kidney and liver (including Cytochrome P450 abnormalities)

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

Version History

Version Modification Description Updated Date

Folder 316063 Full Announcement-FY19 GWIRP IA -> GWIRP FY19 IA PA_GG.PDF

Packages

Agency Contact Information: CDMRP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
Email: help@eBRAP.org
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
12.420 PKG00251064 May 16, 2019 Oct 03, 2019 View

Package 1

Mandatory forms

316063 RR_SF424_2_0-2.0.pdf

316063 AttachmentForm_1_2-1.2.pdf

316063 RR_PersonalData_1_2-1.2.pdf

316063 RR_KeyPersonExpanded_2_0-2.0.pdf

316063 RR_Budget_1_4-1.4.pdf

316063 PerformanceSite_2_0-2.0.pdf

Optional forms

316063 RR_SubawardBudget30_1_4-1.4.pdf

2025-07-09T16:39:13-05:00

Share This Post, Choose Your Platform!

About the Author: